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Abstract
The chaperone function of the ER-residing heat shock protein gp96 plays an important role in protein physiology and has
additionally important immunological functions due to its peptide-binding capacity. Low amounts of gp96 stimulate
immunity; high quantities induce tolerance by mechanisms not fully understood. A lack of gp96 protein in intestinal
macrophages (IMACs) from Crohn`s disease (CD) patients correlates with loss of tolerance against the host gut flora, leading
to chronic inflammation. Since gp96 shows dose-dependent direction of immunological reactions, we studied primary
IMACs and developed cell models to understand the regulation of gp96 expression. Induction of gp96-expression was
higher in in vitro differentiated dendritic cells (i.v.DCs) than in in vitro differentiated macrophages (i.v.MACs), whereas
monocytes (MOs) expressed only low gp96 levels. The highest levels of expression were found in IMACs. Lipopolysaccharide
(LPS), muramyl dipeptide (MDP), tumour necrosis factor (TNF), and Interleukin (IL)-4 induced gp96-expression, while IL12, IL-
17, IL-23 and interferon (IFN)-c were not effective indicating that Th1 and Th17 cells are probably not involved in the
induction of gp96. Furthermore, gp96 was able to induce its own expression. The ER-stress inducer tunicamycin increased
gp96-expression in a concentration- and time-dependent manner. Both ulcerative colitis (UC) and CD patients showed
significantly elevated gp96 mRNA levels in intestinal biopsies which correlated positively with the degree of inflammation of
the tissue. Since gp96 is highly expressed on the one hand upon stress induction as during inflammation and on the other
hand possibly mediating tolerance, these results will help to understand the whether gp96 plays a role in the
pathophysiology of inflammatory bowel disease (IBD).
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Introduction
The intestinal mucosa constitutes the primary anatomic and
immunological barrier to the gut lumen preventing uncontrolled
entry of food and commensal antigens into the body. The innate
immune system of the intestine has evolved to benefit both the host
and the microflora by keeping homeostasis of the epithelial cell
tissue layer and tolerance versus the gut bacteria, while being able
to elicit specific responses towards invading pathogens. Any
disturbance in this host-commensal relationship may imbalance
the innate immune signalling leading to intestinal inflammation in
the genetically susceptible host. Inflammatory bowel disease (IBD)
is regarded to be a consequence of such a disturbance of intestinal
barrier and innate immune functions [1,2].
A central component of the intestinal innate immune system are
intestinal macrophages (IMACs) representing the largest popula-
tion of macrophages in the body [3–5]. They originate from
immigrating monocytes. Upon their differentiation in the mucosal
environment IMACs downregulate the expression of many pattern
recognition receptors (PRRs) and co-stimulators leading to a
tolerogenic phenotype in healthy individuals [6,7]. In contrast to
many cell surface receptors [6,8] and proteasomal components
important for antigen presentation (unpublished data), which also
undergo downregulation in IMACs, the glycoprotein (gp) 96 is
strongly induced during the differentiation of monocytes to
IMACs [9].
Gp96 is a multifunctional endoplasmic reticulum (ER)-resident
protein that has recently gained interest in being a mediator
between innate and adaptive immune reactions [10–11]. Further-
more, recent data connect a loss of gp96 to a perturbance in ER
stress signalling [12]. ER stress occurs upon accumulation of mis-
or unfolded proteins in the ER [13–15]. ER stress has recently
been speculated to be a potential initiator of intestinal inflamma-
tion [16], while it formerly has only been observed concomitantly
with intestinal inflammation [17–19].
Originally gp96 was identified as a heat shock protein (HSP)
[20]. Like other HSPs it is phylogenetically highly conserved in all
prokaryotes and eukaryotes [21–25]. What is relevant for
immunological reactions is the peptide binding capacity of gp96
in the ER where the peptides originate from intracellular
degradation of proteins [11,26]. Gp96-peptide-complexes released
upon stress and necrosis can lead to different immunological
outcomes. Specific uptake [27–30] by antigen presenting cells
triggers cross-presentation [30] of the peptide on major histocom-
patibility complex (MHC) I conferring either immunity or
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tolerance towards the cells where gp96 had been isolated from
[10,31–33]. Speculation about direct interaction of gp96 with toll-
like receptors has been linked to the activation of macrophages
(MWs) and dendritic cells (DCs) [34,35], although this has been
under debate due to the possibility of contaminating lipopolysac-
charides (LPS) in the applied recombinant gp96 [36,37]. Gp96
may act as an efficient adjuvant to initiate immune responses.
In this context it is striking that gp96 was not immunohisto-
chemically detectable in IMACs from Crohn’s Disease (CD)
patients, whereas it is abundantly expressed in tolerogenic IMACs
of healthy individuals [9]. Since the presence of gp96 protein
coincides with healthy and inflamed regions in the colon, we
investigated the regulation of expression in IMACs and in i.v.DCs
and i.v.MACs, both basal and after stimulation with pro-
inflammatory cytokines, bacterial cell envelope components as
well as purified human gp96.
Results
The expression of gp96 is induced upon differentiation
into IMACs, i.v.MACs and i.v.DCs
In the gut mucosal environment gp96 mRNA expression was
induced to high levels (between 30 and 100-fold) in IMACs (Fig. 1)
in comparison with their progenitor cells monocytes showing the
lowest expression of the tested cell types. There was overall no
significant difference between expression levels of gp96 in IMACs
from control and IBD patients (Fig. 1A, B). There was no
correlation between expression levels of gp96 and patient age or
gender. After one week of in vitro-differentiation an induction of
mRNA expression was detected (up to 15-fold) for i.v.DCs but
only a moderate induction for i.v.MACs was observed (Fig. 2A).
Analysis of protein levels of both cell types confirmed this
observation (Fig. 2B, C), albeit to a much lesser extent than on
mRNA level (only about 1.5-fold increase in i.v.DCs, Fig. 2C).
TNF stimulation leads to an upregulation of gp96
expression
In order to investigate the regulation of gp96 expression, we
challenged the cells with stimuli present in the mucosal environ-
ment and known to initiate immune and/or inflammatory
responses. These were the cytokines TNF, IFN-c, granulocyte-
macrophage colony stimulating factor (GM-CSF), IL-4, IL-12, IL-
Figure 1. mRNA expression of gp96 in IMACs from IBD and
control patients. Control patients comprised 31 with cancer, 3 with
fistulae, 1 with volvulus, and 1 healthy patient, 8 with diverticulitis, and
3 with diverticulosis. IBD patients comprised 6 CD and 5 UC patients. (A)
Average expression (vs. GAPDH) from IMACs of control (n = 47) and IBD
patients (n = 11). Error bars represent the standard deviation of the
mean of all analysed patients. (B) Selected expression levels of IMACs
from single patients. The expression in MOs was used as a reference
and set to 1. Error bars represent the standard deviation of a single
experiment measured in triplicate.
doi:10.1371/journal.pone.0076350.g001
Figure 2. Regulation of gp96 expression during differentiation
of MOs to i.v.DCs and i.v.MACs. (A) Relative mRNA levels of gp96
(vs. GAPDH) by RT-PCR. Results are representative for three experiments
in total. A typical result is shown where the basal level in MOs is set as a
reference. Error bars represent the standard deviation of a single
experiment measured in triplicate. (B) Western blot analysis of gp96. (C)
Densitometric analysis. AU: arbitrary units, kDa: Kilodalton.
doi:10.1371/journal.pone.0076350.g002
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17, and IL-23. During a first course of experiments we found
consistently that the highest levels of gp96 mRNA were induced
after two hours of stimulation, independently of the stimulus.
Therefore, in the following experiments samples for RNA isolation
were always taken after two hours of stimulation.
Stimulation of i.v.DCs and i.v.MACs (Fig. 3A) as well as IMACs
from control and IBD patients (Fig. 3B) with cytokines revealed
that only some were able to induce gp96 expression. Among all
tested cytokines TNF was the most potent: apart from irresponsive
IMACs of control patients all cell types increased the synthesis of
gp96 mRNA between 3.5- (i.v.DCs) and 2-fold (i.v.MACs and
IMACs from IBD patients), respectively, while IFN-c was able to
induce higher levels only in i.v.DCs (2-fold). Upon incubation with
IL-4 i.v.MACs and IMACs from UC patients synthesized 2- and
2.5-fold more gp96 mRNA, respectively. IL-12 induced a 2-fold
rise only in IMACs from UC patients. The other cytokines IL-17,
IL-23 and GM-CSF did not regulate expression of gp96 under the
conditions studied.
The bacterial cell envelope components LPS and MDP
induce increased gp96 mRNA levels
IMACs from IBD patients, i.v.DCs and i.v.MACs showed a
high induction of gp96 mRNA after stimulation with the bacterial
cell envelope components LPS and MDP. In contrast the hardly
responsive IMACs from non-IBD control patients were only
slightly increasing expression after stimulation with LPS (Fig. 3C).
i.v.DCs and i.v.MACs were observed to be similarly responsive:
LPS induced mRNA synthesis about 4-fold, MDP approximately
3-fold. Both components induced about equal levels of gp96
mRNA in IMACs from CD patients, while IMACs from UC
strongly increased gp96 mRNA synthesis after stimulation with
LPS (13-fold). IMACs from non-IBD patients only slightly
changed gp96 mRNA levels upon stimulation.
Gp96 induces its own expression
The results of stimulation experiments with purified human
gp96 are shown in Fig. 3D. Self-induction of gp96 was observed in
i.v.MACs (about 2-fold) and IMACs from IBD patients. High
expression levels were detected in IMACs from UC patients (19-
fold). In IMACs from CD patients gp96 mRNA expression was
only slightly induced (about 1.5-fold). Again IMACs from non-
IBD patients were not responsive.
ER-stress induces gp96 expression in cell lines and
primary cells
The well-known inducer of ER stress tunicamycin was tested to
increase the expression of gp96 in MM6 cells and i.v.DCs. After
12 hours of stimulation with 0.2 mg/mL tunicamycin, gp96
Figure 3. Stimulus-dependent expression of gp96 mRNA in human innate immune cells. Relative mRNA levels of gp96 are shown (vs.
GAPDH/b-actin) in i.v.DCs, i.v.MACs and IMACs from control, UC, and CD patients. Cells were stimulated for 2 h. Results are representative for three
experiments. Error bars represent the standard deviation of a single experiment measured in triplicate. (A) Stimulation of i.v.DCs and i.v.MACs with
cytokines. (B) Stimulation of IMACs with cytokines. (C) Stimulation of i.v.DCs, i.v.MACs and IMACs with bacterial envelope components. (D) Stimulation
of i.v.MACs and IMACs with gp96 protein. c: unstimulated control; TNF: tumour necrosis factor, IFN-c: interferon-gamma, IL: interleukin IL-12, IL-17, IL-
23 (100 ng/mL each); GM-CSF: granulocyte-macrophage-colony stimulating factor (50 ng/mL); IL-4 (5 ng/mL); LPS: lipopolysaccharide, MDP:
muramyl-dipeptide (10 ng/mL each); gp96: glycoprotein 96 (10 mg/mL).
doi:10.1371/journal.pone.0076350.g003
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mRNA levels were induced 7.5-fold in MM6 cells (Fig. 4A), 2 mg/
mL of tunicamycin increased the level 9-fold. After 2 hours only a
slight induction of gp96 mRNA levels was observed. In i.v.DCs the
induction of gp96 mRNA was 10-fold after 24 h with 2 mg/mL of
tunicamycin (Fig. 4D). In comparison gp96 protein levels upon
incubation with tunicamycin increased 1.2- to 2.5-fold, depending
on the incubation time, the concentration and the cell type
(Fig. 4B, E, F). Interestingly the lower concentration of
tunicamycin was gradually inducing gp96 synthesis over 24 h,
while the higher concentration reached maximal induction already
after 12 h (Fig. 4C).
Expression of gp96 is elevated in biopsies from colon and
terminal ileum of IBD patients
In intestinal biopsies from colon and terminal ileum gp96
mRNA levels were significantly elevated in IBD patients suffering
from UC or CD as compared to control patients (Fig. 5A). A
paired analysis of non-inflamed versus inflamed regions within
individual patients confirmed the correlation between inflamma-
tory status of the intestinal tissue biopsy and elevated gp96 mRNA
levels in UC, and to some extent in CD, but in case of the latter
the observed changes were not significant (Fig. 5B). We could not
find any direct impact of IBD-related medication. However, it
might be due to the limited number of patients that we did not find
any pattern that was associated with the applied medication.
Discussion
In this study we presented data on mRNA levels of the immune-
relevant HSP gp96 in innate immune cells. The regulation of
expression of immuno-relevant HSPs has not been fully under-
stood yet. It is well known though that they are up-regulated in
stress situations like e. g. heat shock, ER stress and hypoxia [24],
and also during the differentiation of immune cells like e. g.
IMACs [9]. Accordingly we observed a high induction of gp96
mRNA expression in our model of i.v.DCs. A lower induction was
detected in i.v.MACs. IL-4 used in the differentiation process for
i.v.DCs was able to induce an increased expression of gp96 also in
i.v.MACs. [38] Additionally we clearly showed up-regulation of
gp96 by the ER-stress inducer tunicamycin in the monocytic cell
line MM6. This reflects the function of gp96 as a chaperone on the
one hand (up-regulation during ER-stress) and as a mediator of
immune responses on the other hand (up-regulation during
differentiation of immune cells). The increase in expression of
chaperones during ER-stress has been well characterized by three
different unfolded protein response (UPR) pathways involving
inositol-requiring enzyme (IRE) 1, protein kinase RNA-like ER
kinase (PERK), and activating transcription factor (ATF) 6 [15].
Figure 4. ER stress induction of gp96 in MM6 and i.v.DCs. Panels A–C show the results for MM6 after 2, 12, and 24 hours of incubation with
tunicamycin, panels D-F for i.v.DCs after 24 hours. Results are representative for three experiments. Three concentrations of tunicamycin were used to
induce ER-stress in MM6 cells: 0, 0.2, and 2 mg/mL. (A, D) Relative mRNA levels of gp96 (vs. b-actin). Error bars represent the standard deviation of a
single experiment measured in triplicate. (B, E) Western blot analysis of gp96. (C, F) Densitometric analysis. AU: arbitrary units.
doi:10.1371/journal.pone.0076350.g004
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However, what triggers the high induction of gp96 protein during
the differentiation of IMACs in healthy individuals still needs to be
elucidated. In comparison to IMACs i.v.MACs in our differenti-
ation model expressed only slightly higher gp96 levels, although
both develop from monocytes. Candidates involved in the
regulation of gp96 expression in immune cells might be Ets
repressor complexes that were described to arrest the cell cycle
during terminal differentiation of monocytes into macrophages
[39]. The observed lack of gp96 protein in CD-IMACs is most
probably post-transcriptionally regulated, since mRNA levels were
almost unchanged compared to anergic control IMACs [9].
Identifying regulators of expression of gp96 mRNA levels is a
first step to clarify the mechanism(s) involved in the change of gene
activity. Increased levels of gp96 were induced in cells challenged
with pro-inflammatory stimuli as TNF, the bacterial cell envelope
components LPS and MDP, additionally with gp96 protein itself
and weakly with IL-4. This hints to TLRs, TNF-, and gp96-
receptors as putative starting points for the activation of gp96 gene
expression in innate immune cells. No induction was observed
after stimulation with IFN-c, IL-12, IL-17, and IL-23 usually
found in inflamed mucosa of IBD patients in elevated concentra-
tions [1,2,40]. The set of non-inducing cytokines seemed to
exclude Th1 (typically secreting IFN-c [41,42]) and Th17
(secreting IL-17 [40]) cells from the transcriptional up-regulation
of gp96 in innate immune cells.
The cytokine TNF and LPS and MDP – altogether pro-
inflammatory – were as well inducers of gp96 expression which
matched the elevated gp96 mRNA levels that correlated with the
degree of inflammation in biopsies from IBD patients. Although a
lack of expression of gp96 in macrophages is associated with CD
[9], a higher overall expression in biopsies from IBD patients was
detected in the present study which was consistent with the data
from epithelial cells of IBD patients [9,14]. It would be interesting
to identify the cell type responsible for the elevated gp96 mRNA
levels in biopsies consisting of epithelial and muscle cells,
macrophages, dendritic cells and fibroblasts. However, it remains
unclear whether changes in gp96 levels are cause or consequence
of inflammatory processes in those patients.
After stimulation, we observed a higher change in mRNA than
in protein levels of gp96. This could either mean that translation
was partially inhibited or that already synthesized protein was lost
because of secretion or intracellular degradation. Both processes
were already considered to explain the absence of gp96 protein in
IMACs from Crohn’s disease patients [9]. Another possibility
includes the difficulty to detect changes of abundantly expressed
proteins like gp96 [12], since considerable amounts of newly
synthesized protein would be needed to result in a detectable
change. Accordingly in breast cancer and B cell lymphoid cells
with a very low basal expression, high protein levels of gp96 upon
stimulation with the cytokines IL-2 and IFN-c were detected [43].
Since data for mRNA expression were not presented, it is
impossible to judge if they observed the same discrepancy between
transcription and translation as we did.
Being an essential protein during early embryogenesis – the
genetic knock-out is lethal [44] – a special relevance of gp96
involved in developing inflammatory and autoimmune diseases
comes from the fact that apparently changes in its intracellular
levels and distribution are crucial [9,45]. Our experimental set-up
using crude extracts did not allow for either the detection of
intracellular relocation or secretion of gp96. Only recently the
secretion of the cytoplasmic analogue HSP90b had been reported
in culture supernatants of osteosarcoma cells [46], but in general
HSPs of the HSP70 group have been found to be actively secreted
[47].
The regulation of gp96 gene expression depends on the
promoter containing consensus sequences of various transcription
factors. Which ones are finally initiating transcription is a matter of
how stimuli, signalling pathways and the present subset of
regulatory proteins are integrated. In this regard it was an
interesting and new finding in our experiments that gp96 induced
its own expression. This raises the question of the underlying
physiological processes. Chronologically recognition, binding and
uptake by specific receptors should precede signalling pathways
and finally recruitment of the transcriptional machinery to the
gp96 promoter. Three gp96-receptors are known in humans: the
a2-macroglobulin receptor CD91 [48], the scavenger receptors
SR-A (Type A) [27] and SREC-I (Type F) [28], all involved in
different signalling pathways. Also an unspecific uptake has been
considered as possibly relevant in the uptake of gp96 [49]. In order
to get an insight into the mechanism of self-induction future
studies will aim at investigating release, uptake, and subsequent
intracellular distribution of gp96. This will clarify further whether
the regulation of gp96 expression plays a role during CD
pathophysiology.
Figure 5. Analysis of gp96 mRNA in intestinal biopsies from
IBD and control patients. (A) Relative mRNA levels of gp96 (vs. b-
actin) in biopsies from colon and terminal ileum of control and IBD
patients. (B) Paired analysis of gp96 expression levels within individual
patients (involved vs. non-involved). Error bars represent standard error
of the mean. * p,0.05, ** p,0.001, *** p,0.0001.
doi:10.1371/journal.pone.0076350.g005
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Materials and Methods
Isolation of Human Peripheral Blood Monocytes
Monocytes (MOs) were isolated according to [50] using FicollH
gradient centrifugation and labelling the interphase fraction with
magnetic microbeads (Monocyte Isolation Kit II, Miltenyi Biotec,
Bergisch Gladbach, Germany) and a final purification with a
magnetic cell sorter according to the manufacturer’s instructions
(AutoMACS, Miltenyi Biotec, Germany).
Patients
Primary human IMACs were obtained from surgical specimens
from intestinal mucosa of 6 CD, 5 UC, 8 diverticulitis, 3
diverticulosis, and 36 control patients (31 with carcinoma, 3 with
fistulae, 1 with volvulus, and 1 healthy patient) undergoing large or
small bowel surgery. This study was approved by the Cantonal
Ethics Committee of Zurich and performed according to the
Declaration of Helsinki (EK: 1755). For analysis of mRNA
expression in intestinal biopsies from IBD patients cDNA samples
were obtained from an earlier study [51].
Isolation of IMACs
Human IMACs were isolated from surgical specimens accord-
ing to a previously established protocol [6]. Briefly, mucosa was
incubated in HBSS with 1 mmol/l EDTA for 15 minutes at 37uC
in order to remove intestinal epithelial cells. Subsequently, mucosa
was digested in 2 ml PBS with 1 mg/ml collagenase type I
( = 336 U/ml), 0.3 mg/ml DNase (Boehringer, Mannheim, Ger-
many), and 0.2 mg/ml hyaluronidase without fetal calf serum at
37uC for 30 minutes. The liberated lamina propria cells were
submitted to FicollH density gradient centrifugationfor isolation of
mononuclear cells. Purification of IMACs was achieved by
labelling the interphase fraction with immunomagnetic microbe-
ads armed with CD33 antibody, and magnetic cell sorting
according to manufacturer’s instructions (AutoMACS, Miltenyi
Biotec, Germany).
Generation of in vitro-differentiated Macrophages
(i.v.MACs)
I.v.MACs were isolated according to a previously established
protocol [52]. 16106 monocytes were cultivated in Teflon bags for
one week under optimal conditions (37uC, 5% CO2). Generation
of macrophages was achieved by addition of 2% hunan AB serum.
Detachment of the cells from the Teflon bag was achieved by
incubation at 4uC.
Generation of in vitro-differentiated Dendritic Cells
(i.v.DCs)
I.v.DCs were generated according to a previously established
protocol [50]. Monocytes were cultivated in flasks for one week
under optimal conditions with IL-4 (5 ng/mL) and GM-CSF
(50 ng/mL) added for differentiation into i.v.DCs.
Cell culture
The monocytic cell line Mono Mac-6 (MM6, obtained from
DMSZ) was maintained in MM6 media according to the
American Type Culture Collection (ATCC) and passaged three
times a week to keep cell counts below 16106/mL.
Stimulation of cells
Primary cells were adjusted to a density of 16106/mL, the
monocytic cell line MM6 was adjusted to 56105/mL. The
stimulating compounds were added for 2 hours (for total RNA
isolation) and between 4 and 24 hours (for protein analysis),
respectively. In order to induce ER-stress in cells tunicamycin
(MM6: 0.2, 2 and 20 mg/mL, i.v.DCs: 2 mg/mL) was added for
indicated times from a stock solution of 1 mg/mL in DMSO. After
stimulation the cells were harvested for RNA isolation or protein
extraction.
Quantitative analysis of gene expression
Isolation of total RNA was carried out with the QIAcubeH
system using the silica-based RNeasy method (QIAgen, Hilden,
Germany). The RNA concentration was determined with the
Nanodrop spectrophotometer ND 1000 (Wilmington, Delaware,
USA) and adjusted to the lowest concentrated sample within the
experimental setup. The adjusted RNA was reverse-transcribed
with the ‘‘High-Capacity cDNA Reverse Transcription Kit’’ from
Applied Biosystems (Carlsbad, California, USA). Real-time
quantitative PCR by TAQMAN (Applied Biosystems) was used
to determine the expression of genes encoding gp96 and the house
keeping genes glyceraldehyde-3-phosphate dehydrogenase or b-
actin. Two-step PCR was performed and fluorescence was
detected at the end of each extension step. Gene expression was
calculated using the 22DDCT.
Western blotting
Cell lysates were adjusted to a concentration of 1 mg/mL.
Samples (10 to 20 mg per lane) were separated using 10% SDS-
PAGE. Antibodies against gp96 (Stressgen, Ann Arbor, Michigan,
USA), b-actin (Sigma, St. Louis, Missouri) and GAPDH (AbD
Serotec, Oxford, UK) were used to detect the corresponding
antigens. Labelled bands were detected using the Western
Lightning Plus ECL detection system from Perkin Elmer
(Waltham, Massachusetts, USA). For band intensity analysis
OptiQuant 2.50 from Packard Instruments (Meriden, Connecti-
cut, USA) was used.
Statistical analysis
The statistical significance of gp96 mRNA expression levels in
IBD patients was determined using ANOVA by GraphPad Prism 5.
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